BAFF-R CAR T Therapy for Leukemia and Lymphoma | City of Hope
Вставка
- Опубліковано 26 вер 2019
- Larry Kwak, M.D., Ph.D., on BAFF-R CAR T therapy that will be used in a 2020 clinical trial for patients who relapsed after CD19 immunotherapy treatments and may potentially be used as a first-line of CAR T cell therapy treatment.
